Euler Biologics

San Francisco, United States

Euler Biologics develops antibody-based therapeutics aimed at supporting physical function and independence in aging populations.

$493K raised

Oct 2024

Venture - Series Unknown

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Gaingels

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Euler Biologics

How much funding has Euler Biologics raised?

Euler Biologics has raised $493K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.

Who are Euler Biologics's investors?

Euler Biologics's investors include Gaingels.

Where is Euler Biologics headquartered?

Euler Biologics is headquartered in San Francisco, United States.

What does Euler Biologics do?

Euler Biologics develops antibody-based therapeutics aimed at supporting physical function and independence in aging populations.

What stage is Euler Biologics at?

Euler Biologics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2024.

MLA

"Euler Biologics — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/euler-biologics. Accessed July 3, 2026.

APA

VCBacked. (2024). Euler Biologics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/euler-biologics

Wikipedia (cite web)

{{cite web |title=Euler Biologics — Funding & Investors |url=https://www.vcbacked.co/company/euler-biologics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2024.